These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 35672893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
    Lim YS, Gwak GY, Choi J, Lee YS, Byun KS, Kim YJ, Yoo BC, Kwon SY, Lee HC.
    J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.
    Lee KS, Kweon YO, Um SH, Kim BH, Lim YS, Paik SW, Heo J, Lee HJ, Kim DJ, Kim TH, Lee YS, Byun KS, Kim D, Lee MS, Yu K, Suh DJ.
    Clin Mol Hepatol; 2017 Dec; 23(4):331-339. PubMed ID: 28946736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication.
    Wang L, Ye Z, Liang H, Zhang B, Xu L, Feng Z, Liu S, Shi W.
    Am J Transl Res; 2016 Dec; 8(3):1593-600. PubMed ID: 27186284
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
    Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, Sievert W, Wong D, Lovegren M, Cohen D, Llamoso C.
    Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H.
    World J Gastroenterol; 2015 Apr 21; 21(15):4644-51. PubMed ID: 25914474
    [Abstract] [Full Text] [Related]

  • 12. Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial.
    Yang JM, Chen LP, Wang YJ, Lyu B, Zhao H, Shang ZY, Li J, Fan ZY, Wu SD, Ming X, Li X, Huang SP, Cheng JL.
    Chin Med J (Engl); 2020 Jul 20; 133(14):1639-1648. PubMed ID: 32568867
    [Abstract] [Full Text] [Related]

  • 13. Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
    Lim YS, Lee YS, Gwak GY, Byun KS, Kim YJ, Choi J, An J, Lee HC, Yoo BC, Kwon SY.
    Hepatology; 2017 Sep 20; 66(3):772-783. PubMed ID: 28370419
    [Abstract] [Full Text] [Related]

  • 14. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
    Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD.
    World J Gastroenterol; 2013 Oct 07; 19(37):6278-83. PubMed ID: 24115827
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Long-Term Corticosteroid Monotherapy in 26 Cases of Nephrotic Syndrome with Biopsy-Proven Membranous Nephropathy Induced by Seronegative Hepatitis B Virus-Associated Glomerulonephritis.
    Zhang Y, Chen S, Yang D, Liu J, Zhang X, Yang X, Han H, Yang D.
    Nephron; 2021 Oct 07; 145(2):113-122. PubMed ID: 33561853
    [Abstract] [Full Text] [Related]

  • 16. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
    Lim YS, Yoo BC, Byun KS, Kwon SY, Kim YJ, An J, Lee HC, Lee YS.
    Gut; 2016 Jun 07; 65(6):1042-51. PubMed ID: 25800784
    [Abstract] [Full Text] [Related]

  • 17. Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
    Chaung KT, O'Brien C, Ha NB, Nguyen NH, Trinh HN, Nguyen MH.
    J Clin Gastroenterol; 2016 Apr 07; 50(4):338-44. PubMed ID: 26646801
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H.
    J Viral Hepat; 2013 Apr 07; 20 Suppl 1():40-5. PubMed ID: 23458523
    [Abstract] [Full Text] [Related]

  • 19. Adefovir and lamivudine combination therapy in patients with entecavir-resistant chronic hepatitis B: antiviral responses and evolution of mutations.
    Yim HJ, Lee HJ, Suh SJ, Seo YS, Kim CW, Lee CD, Park SH, Lee MS, Park CK, Chae HB, Kim MY, Baik SK, Kim YS, Kim JH, Lee JI, Lee JW, Hong SP, Um SH.
    Intervirology; 2014 Apr 07; 57(5):239-47. PubMed ID: 24993731
    [Abstract] [Full Text] [Related]

  • 20. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
    Zheng XY, Wei RB, Tang L, Li P, Zheng XD.
    World J Gastroenterol; 2012 Feb 28; 18(8):821-32. PubMed ID: 22371643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.